Prognostic Value of the Extent of Lymphadenectomy for Overall Survival Among Patients with Non-muscle Invasive Bladder Cancer, A Retrospective Cohort Study
Authors:
Open Access
- 10 July 2025
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (12) , 9432-9444
Abstract
Background: The purpose of this study was to find out the impact of lymph node dissection (LND) on the prognosis of patients undergoing cystectomy for non-muscle invasive bladder cancer (NMIBC) and determine the minimum number of lymph nodes (LNs) for resection. Patients and Methods: Patients with NMIBC undergoing cystectomy between 2004 and 2015 were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. Propensity score matching and multivariate Cox regression analyses were performed to mitigate the influence of selection bias and control for potential confounding variables. Results: Of 1950 patients with NMIBC, 1353 underwent LND, of which 58 (4.2%) exhibited positive LNs. LND were associated with better prognosis in the whole cohort (P < 0.001). Patients who had positive lymph nodes were found to have the worst prognosis (P < 0.001). Restricted cubic spline (RCS) found that patients with at least 8 LNs examined show longer survival than those with nLNE < 8, which was further validated in multivariable Cox regression [HR 0.66 (0.59, 0.76)]. Subgroup analysis indicated that nLNE ≥ 8 was associated with significantly improved overall survival in T1 and Tis patients both before and after PSM, while for Ta patients, the impact of LND or nLNE ≥ 8 on prognosis was insignificant. Additionally, for patients with negative lymph node, nLNE ≥ 8 still resulted in better prognosis [HR 0.73 (0.61, 0.87)]. Furthermore, sensitivity analyses replicated the same results in patients more than 80 years old and found that patients with nLNE ≥ 8 demonstrated superior prognosis than those with less than 8 lymph nodes retrieved. Conclusions: Among patients with NMIBC, it is crucial to remove eight or more lymph node effectively during cystectomy, except in Ta subgroup.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (L248068)
This publication has 27 references indexed in Scilit:
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesEuropean Urology, 2025
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesEuropean Urology, 2023
- Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal diseaseLung Cancer, 2022
- European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)European Urology, 2022
- Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized TrialEuropean Urology, 2019
- Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapyCancer Treatment Reviews, 2018
- Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic CancersEuropean Urology, 2018
- Prognostic impact of nodal micrometastasis in early esophageal cancerEuropean Journal of Surgical Oncology, 2012
- Lymph Node Dissection Technique Is More Important Than Lymph Node Count in Identifying Nodal Metastases in Radical Cystectomy Patients: A Comparative Mapping StudyEuropean Urology, 2011
- Association between lymphangiogenesis-/micrometastasis- and adhesion-related molecules in resected stage I NSCLCLung Cancer, 2010